Marie C. Hasselluhn - Concepedia

Author

Marie C. Hasselluhn

Columbia University Irving Medical Center ORCID

Also Known As

Hasselluhn, Marie Christin, Lagana, Stephen M., M Hasselluhn, Marie C Hasselluhn, Marie C. Hasselluhn, Marie Christin Hasselluhn, Marie Hasselluhn, Roth, Jennifer A.

Publications

323

Citations

H-Index

Concepts

All Affiliations

Columbia University Irving Medical Center Columbia University Mayo Clinic University of Göttingen Klinikum rechts der Isar

About

Marie C. Hasselluhn is an author at Columbia University Irving Medical Center specializing in tumor biology, cell signaling, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	43
2	Cell Biology	1	1	43
3	Immunology	1	1	43
4	Cancer Cell Biology	1	1	43
5	Cancer Genetics	1	1	43

Marie C. Hasselluhn

Publications

267

Citations

H-Index

Page 1

	Year	Citations
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton, Nature	2024	150
NFATc4 Regulates <i>Sox9</i> Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation Jin‐San Zhang, Nai-Ming Chen, Marie C. Hasselluhn, Stem Cells International GeneticsImmunologyPancreatic Cancer InitiationCancer BiologyTumor Biology	2015	43
Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression Marie C. Hasselluhn, Amanda R. Decker-Farrell, Lukas Vlahos, Cancer Discovery	2023	20
Stromal Features of the Primary Tumor Are Not Prognostic in Genetically Engineered Mice of Pancreatic Cancer Marie C. Hasselluhn, Lukas Klein, Melanie S. Patzak, Cells	2019	17
Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression Marie C. Hasselluhn, G. Schmídt, Volker Ellenrieder, Cell Death and Disease	2019	16
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies Marie C. Hasselluhn, Denise Schlösser, Lennart Versemann, Gastroenterology	2023	11
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma Urszula N. Wasko, Jingjing Jiang, Alvaro Curiel-Garcia,	2023	10

Page 1